US Stock MarketDetailed Quotes

CNTX Context Therapeutics

Watchlist
  • 2.6100
  • -0.0500-1.88%
Close Aug 16 16:00 ET
195.75MMarket Cap-2718P/E (TTM)

Context Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
303.92%101.54M
-66.11%10.09M
-59.29%14.45M
-59.29%14.45M
-45.02%21.68M
-41.43%25.14M
-34.90%29.77M
-28.48%35.5M
-28.48%35.5M
9,306.40%39.43M
-Cash and cash equivalents
303.92%101.54M
-66.11%10.09M
-59.29%14.45M
-59.29%14.45M
-45.02%21.68M
-41.43%25.14M
-34.90%29.77M
-28.48%35.5M
-28.48%35.5M
9,306.40%39.43M
Other current assets
-54.83%1.16M
-55.14%949.49K
-32.21%1.6M
-32.21%1.6M
-48.51%1.29M
62.89%2.57M
87.47%2.12M
45.43%2.36M
45.43%2.36M
13,568.19%2.51M
Total current assets
270.63%102.7M
-65.38%11.04M
-57.61%16.05M
-57.61%16.05M
-45.23%22.97M
-37.73%27.71M
-31.95%31.89M
-26.15%37.85M
-26.15%37.85M
9,485.42%41.94M
Non current assets
Net PPE
-63.81%10.39K
-76.13%12.96K
-80.48%15.52K
-80.48%15.52K
-82.69%18.09K
-77.79%28.7K
-64.17%54.27K
--79.54K
--79.54K
--104.51K
-Gross PPE
----
----
-80.48%15.52K
-80.48%15.52K
-82.69%18.09K
-77.79%28.7K
-64.17%54.27K
--79.54K
--79.54K
--104.51K
Other non current assets
----
----
----
----
----
-64.58%24K
9.12%26.19K
-35.01%32.75K
-35.01%32.75K
--39.31K
Total non current assets
-80.29%10.39K
-83.90%12.96K
-86.17%15.52K
-86.17%15.52K
-87.42%18.09K
-73.24%52.7K
-54.15%80.46K
122.84%112.29K
122.84%112.29K
-92.11%143.83K
Total assets
269.96%102.71M
-65.43%11.05M
-57.69%16.06M
-57.69%16.06M
-45.37%22.99M
-37.89%27.76M
-32.03%31.97M
-26.00%37.97M
-26.00%37.97M
1,762.65%42.08M
Liabilities
Current liabilities
Payables
-48.65%611.51K
69.00%2.05M
154.51%2.38M
154.51%2.38M
22.26%1.83M
25.95%1.19M
166.09%1.21M
-48.73%936.33K
-48.73%936.33K
-51.52%1.49M
-accounts payable
-48.65%611.51K
69.00%2.05M
154.51%2.38M
154.51%2.38M
22.26%1.83M
25.95%1.19M
166.09%1.21M
-48.73%936.33K
-48.73%936.33K
-51.52%1.49M
Current accrued expenses
-74.33%541.28K
-81.77%315.7K
-15.80%1.15M
-15.80%1.15M
15.05%2.09M
35.83%2.11M
113.51%1.73M
99.04%1.36M
99.04%1.36M
36.81%1.81M
Current debt and capital lease obligation
----
----
----
----
----
-91.44%7.97K
-65.54%31.67K
--55.08K
--55.08K
--78.2K
-Current capital lease obligation
----
----
--0
--0
--0
-91.44%7.97K
-65.54%31.67K
--55.08K
--55.08K
--78.2K
Other current liabilities
-51.81%11.05K
-69.03%13.7K
-89.82%8.49K
-89.82%8.49K
-5.09%57.22K
-54.22%22.92K
34.13%44.25K
-2.42%83.46K
-2.42%83.46K
--60.29K
Current liabilities
-57.30%1.6M
-19.33%2.61M
30.68%4.19M
30.68%4.19M
14.76%4.6M
23.62%3.76M
101.25%3.23M
5.74%3.21M
5.74%3.21M
-9.01%4.01M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
-57.30%1.6M
-19.33%2.61M
30.68%4.19M
30.68%4.19M
14.76%4.6M
23.30%3.76M
97.36%3.23M
5.74%3.21M
5.74%3.21M
-84.25%4.01M
Shareholders'equity
Share capital
369.74%75K
0.00%15.97K
0.00%15.97K
0.00%15.97K
0.00%15.97K
0.00%15.97K
0.00%15.97K
0.00%15.97K
0.00%15.97K
4,487.93%15.97K
-common stock
369.74%75K
0.00%15.97K
0.00%15.97K
0.00%15.97K
0.00%15.97K
0.00%15.97K
0.00%15.97K
0.00%15.97K
0.00%15.97K
4,487.93%15.97K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-33.51%-73.98M
-42.31%-71.72M
-54.35%-68.05M
-54.35%-68.05M
-51.19%-61.28M
-51.07%-55.41M
-54.16%-50.4M
-50.71%-44.09M
-50.71%-44.09M
-54.93%-40.53M
Paid-in capital
120.41%175.01M
1.31%80.15M
1.37%79.91M
1.37%79.91M
1.35%79.65M
1.39%79.4M
1.34%79.12M
1.71%78.83M
1.71%78.83M
2,565.58%78.59M
Total stockholders'equity
321.19%101.1M
-70.61%8.44M
-65.85%11.87M
-65.85%11.87M
-51.71%18.38M
-42.36%24M
-36.70%28.73M
-28.00%34.76M
-28.00%34.76M
264.00%38.07M
Total equity
321.19%101.1M
-70.61%8.44M
-65.85%11.87M
-65.85%11.87M
-51.71%18.38M
-42.36%24M
-36.70%28.73M
-28.00%34.76M
-28.00%34.76M
264.00%38.07M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 303.92%101.54M-66.11%10.09M-59.29%14.45M-59.29%14.45M-45.02%21.68M-41.43%25.14M-34.90%29.77M-28.48%35.5M-28.48%35.5M9,306.40%39.43M
-Cash and cash equivalents 303.92%101.54M-66.11%10.09M-59.29%14.45M-59.29%14.45M-45.02%21.68M-41.43%25.14M-34.90%29.77M-28.48%35.5M-28.48%35.5M9,306.40%39.43M
Other current assets -54.83%1.16M-55.14%949.49K-32.21%1.6M-32.21%1.6M-48.51%1.29M62.89%2.57M87.47%2.12M45.43%2.36M45.43%2.36M13,568.19%2.51M
Total current assets 270.63%102.7M-65.38%11.04M-57.61%16.05M-57.61%16.05M-45.23%22.97M-37.73%27.71M-31.95%31.89M-26.15%37.85M-26.15%37.85M9,485.42%41.94M
Non current assets
Net PPE -63.81%10.39K-76.13%12.96K-80.48%15.52K-80.48%15.52K-82.69%18.09K-77.79%28.7K-64.17%54.27K--79.54K--79.54K--104.51K
-Gross PPE ---------80.48%15.52K-80.48%15.52K-82.69%18.09K-77.79%28.7K-64.17%54.27K--79.54K--79.54K--104.51K
Other non current assets ---------------------64.58%24K9.12%26.19K-35.01%32.75K-35.01%32.75K--39.31K
Total non current assets -80.29%10.39K-83.90%12.96K-86.17%15.52K-86.17%15.52K-87.42%18.09K-73.24%52.7K-54.15%80.46K122.84%112.29K122.84%112.29K-92.11%143.83K
Total assets 269.96%102.71M-65.43%11.05M-57.69%16.06M-57.69%16.06M-45.37%22.99M-37.89%27.76M-32.03%31.97M-26.00%37.97M-26.00%37.97M1,762.65%42.08M
Liabilities
Current liabilities
Payables -48.65%611.51K69.00%2.05M154.51%2.38M154.51%2.38M22.26%1.83M25.95%1.19M166.09%1.21M-48.73%936.33K-48.73%936.33K-51.52%1.49M
-accounts payable -48.65%611.51K69.00%2.05M154.51%2.38M154.51%2.38M22.26%1.83M25.95%1.19M166.09%1.21M-48.73%936.33K-48.73%936.33K-51.52%1.49M
Current accrued expenses -74.33%541.28K-81.77%315.7K-15.80%1.15M-15.80%1.15M15.05%2.09M35.83%2.11M113.51%1.73M99.04%1.36M99.04%1.36M36.81%1.81M
Current debt and capital lease obligation ---------------------91.44%7.97K-65.54%31.67K--55.08K--55.08K--78.2K
-Current capital lease obligation ----------0--0--0-91.44%7.97K-65.54%31.67K--55.08K--55.08K--78.2K
Other current liabilities -51.81%11.05K-69.03%13.7K-89.82%8.49K-89.82%8.49K-5.09%57.22K-54.22%22.92K34.13%44.25K-2.42%83.46K-2.42%83.46K--60.29K
Current liabilities -57.30%1.6M-19.33%2.61M30.68%4.19M30.68%4.19M14.76%4.6M23.62%3.76M101.25%3.23M5.74%3.21M5.74%3.21M-9.01%4.01M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities -57.30%1.6M-19.33%2.61M30.68%4.19M30.68%4.19M14.76%4.6M23.30%3.76M97.36%3.23M5.74%3.21M5.74%3.21M-84.25%4.01M
Shareholders'equity
Share capital 369.74%75K0.00%15.97K0.00%15.97K0.00%15.97K0.00%15.97K0.00%15.97K0.00%15.97K0.00%15.97K0.00%15.97K4,487.93%15.97K
-common stock 369.74%75K0.00%15.97K0.00%15.97K0.00%15.97K0.00%15.97K0.00%15.97K0.00%15.97K0.00%15.97K0.00%15.97K4,487.93%15.97K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -33.51%-73.98M-42.31%-71.72M-54.35%-68.05M-54.35%-68.05M-51.19%-61.28M-51.07%-55.41M-54.16%-50.4M-50.71%-44.09M-50.71%-44.09M-54.93%-40.53M
Paid-in capital 120.41%175.01M1.31%80.15M1.37%79.91M1.37%79.91M1.35%79.65M1.39%79.4M1.34%79.12M1.71%78.83M1.71%78.83M2,565.58%78.59M
Total stockholders'equity 321.19%101.1M-70.61%8.44M-65.85%11.87M-65.85%11.87M-51.71%18.38M-42.36%24M-36.70%28.73M-28.00%34.76M-28.00%34.76M264.00%38.07M
Total equity 321.19%101.1M-70.61%8.44M-65.85%11.87M-65.85%11.87M-51.71%18.38M-42.36%24M-36.70%28.73M-28.00%34.76M-28.00%34.76M264.00%38.07M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg